In this first of our Outlook 2020 series, Razorfish Health president David Paragamian points to the appointment of Dr. Stephen M. Hahn as commissioner of the FDA as proof positive that we are in the era of oncology. As new oncology drugs flood the market, it’s up to the marketers to provide clear communications for patients and providers, ensuring the right messaging is being delivered.
